THQ News and Press, Tekla Healthcare Opportunies Fund Shares of Beneficial Interest From 02/15/22

The macroeconomic backdrop of Fed interest rate hikes is rapidly deflating overvalued technology companies and "crypto-collectibles." We expect the technology sector to underperform value and biotech. After the sell-off, biotech companies' valuation is close to the 2018 level even tho...

It's time to load up on these opportunities before they are overbought. Don't follow the crowd, be ahead of them. That's key to long-term success. We buy income, reinvest income, and get even more income. For further details see: 2 Big Dividends I'm Loading Up On

THQ pays an attractive monthly distribution to shareholders, it could be due for a boost if markets don't sink too low. The latest volatility has pushed the fund to trade at a premium as its NAV declines further than its price, though it is back at an ever so slight discount. This...

THW is the global counterpart to THQ, though the portfolios overlap quite considerably. THW is relatively overvalued and has been for a while, though THQ's valuation has been getting tight as of late too. The most compelling reason to own THW is for the attractive monthly distribu...

The market frequently offers securities on sale, you need to find them! As technology makes buying easier, it's made selling irrationally easier too. Income investors need to be prepared to snag excellent picks on sale. For further details see: Bargain Alert! 2 High Yiel...

THQ has been a position in my portfolio for quite a few years; currently, it seems as though it'll be there for many more. The solid healthcare names it provides exposure to and the attractive distribution yield are pretty compelling. They have maintained the same monthly distribu...

A reliable selection criterion for building a portfolio of funds that are likely to produce above-average returns over the long haul is the goal of every CEF investor. For me, the flexible combination of a positive NAV since inception, discount on NAV, and leverage represents a practi...

Most investors are ignoring a clear shot at 7%+ dividends double-digit price gains—year in and year out—in a sector everyone should be talking about, but isn’t. That would be healthcare, which is riding a rocket of rising spending: according to the latest number...

On October 8, 2021, Tekla World Healthcare Fund declared its monthly cash distribution of $0.1167 per share. The record date for the monthly cash distribution is October 20, 2021 and the payable date is October 29, 2021. The Fund will trade ex-distribution on October 19, 2021. Note ...

Let’s jump on the market’s September slide and grab ourselves a sweet “double discount” on 358 totally ignored income plays—and some sweet 6%+ dividends, too. And our new income stream will pay us monthly! Going Where Other Dividend Investors Don...